Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ClearPoint Neuro, Inc.CLPT · Entity 2367 | Chief Financial Officer | June 30, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ClearPoint Neuro, Inc.
Report date June 30, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,769 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 1,085 · Balance 103,769 F1: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 2, 2026 20:05 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,085 | $11.93 | $12,944.05 |
DisclosureSEC source: 0001193125-26-294476 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,769 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 18:53 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 32,627 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-108089 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,626 Underlying: Common Stock · 32,627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 18:53 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 16,601 | $11.53 | $191,409.53 |
DisclosureSEC source: 0001193125-26-108089 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,684 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 18:53 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 32,627 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-108089 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 19:10 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 4,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-105965 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 19:10 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 2,109 | $11.62 | $24,506.58 |
DisclosureSEC source: 0001193125-26-105965 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,658 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 19:10 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 4,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-105965 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:55 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 18,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-100320 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:55 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 9,548 | $10.00 | $95,480.00 |
DisclosureSEC source: 0001193125-26-100320 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,622 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:55 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 18,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-100320 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:46 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 10,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-094144 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,328 Underlying: Common Stock · 10,332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:46 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 5,257 | $8.84 | $46,471.88 |
DisclosureSEC source: 0001193125-26-094144 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,405 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:46 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 10,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-094144 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:09 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 66,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-059367 · ownership.xml · derivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,273 Underlying: Common Stock · 66,273 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029. F2 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 23:52 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 407 | $9.57 | $3,894.99 |
DisclosureSEC source: 0001193125-26-002959 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,330 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:30 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionStock Options (right to buy) · Derivative | 3,555 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001193125-25-297322 · ownership.xml · derivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,082 Underlying: Common Stock · 3,555 shares Expires 2033-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:30 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 3,555 | $8.10 | $28,795.50 |
DisclosureSEC source: 0001193125-25-297322 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 21:13 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 376 | $10.15 | $3,816.40 |
DisclosureSEC source: 0000950170-25-093198 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,368 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2025 through June 30, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 23:17 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 4,754 | $13.29 | $63,180.66 |
DisclosureSEC source: 0000950170-25-085709 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,992 F1 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 20:35 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 16,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-039498 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,253 Underlying: Common Stock · 16,313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 20:35 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 8,284 | $13.18 | $109,183.12 |
DisclosureSEC source: 0000950170-25-039498 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,746 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 20:35 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 16,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-039498 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 22:16 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 4,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-038954 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,145 Underlying: Common Stock · 4,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 22:16 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 2,106 | $12.70 | $26,746.20 |
DisclosureSEC source: 0000950170-25-038954 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,717 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 22:16 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 4,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-038954 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 23:45 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 18,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-036672 · ownership.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,765 Underlying: Common Stock · 18,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 23:45 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 9,529 | $13.19 | $125,687.51 |
DisclosureSEC source: 0000950170-25-036672 · ownership.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,677 F2 · shares: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 23:45 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 18,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-036672 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:03 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 51,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032384 · ownership.xml · derivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,660 Underlying: Common Stock · 51,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028. F2 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:57 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,949 | $4.53 | $8,828.97 |
DisclosureSEC source: 0000950170-25-001315 · ownership.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,441 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 20:18 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 1,191 | $11.26 | $13,410.66 |
DisclosureSEC source: 0001285550-24-000103 · wk-form4_1724271506.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,492 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:23 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,913 | $4.58 | $8,761.54 |
DisclosureSEC source: 0001285550-24-000088 · wk-form4_1719955403.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,683 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2024 through June 30, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 23:32 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 4,824 | $5.74 | $27,689.76 |
DisclosureSEC source: 0001285550-24-000081 · wk-form4_1718148728.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,770 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:39 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 81,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-24-000074 · wk-form4_1716410328.xml · derivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,566 Underlying: Common Stock · 81,566 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027. F2 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 8,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-24-000034 · wk-form4_1710363084.xml · derivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,291 Underlying: Common Stock · 8,291 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest as follows: (i) 50% of the total shares on the first anniversary of the grant date and (ii) 50% of the total shares on the second anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units vest as follows: (i) 50% of the total shares on the first anniversary of the grant date and (ii) 50% of the total shares on the second anniversary of the grant date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:40 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 9,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001285550-24-000024 · wk-form4_1709933995.xml · derivative · entry 3 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,530 Underlying: Common Stock · 9,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:40 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 4,718 | $6.24 | $29,440.32 |
DisclosureSEC source: 0001285550-24-000024 · wk-form4_1709933995.xml · nonDerivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,594 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:40 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 9,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-24-000024 · wk-form4_1709933995.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2023 Filed Jan 4, 2024 01:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,479 | $5.77 | $8,533.83 |
DisclosureSEC source: 0001285550-24-000012 · wk-form4_1704333082.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,929 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first business day or last business day of the purchase period. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:42 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 4,958 | $5.01 | $24,839.58 |
DisclosureSEC source: 0001285550-23-000107 · wf-form4_169635131410828.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,450 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 20:37 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 1,166 | $5.34 | $6,226.44 |
DisclosureSEC source: 0001285550-23-000099 · wf-form4_169273661063922.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,408 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:47 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 1,371 | $6.15 | $8,431.65 |
DisclosureSEC source: 0001285550-23-000081 · wf-form4_168859361026445.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,574 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2023 through June 30, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| June 10, 2023 Filed Jun 13, 2023 21:02 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 2,526 | $6.91 | $17,454.66 |
DisclosureSEC source: 0001285550-23-000068 · wf-form4_168669011513033.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,203 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 46,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-23-000028 · wf-form4_167831226592079.xml · derivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,913 Underlying: Common Stock · 46,913 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F3 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. F3 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:51 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 15,637 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001285550-23-000028 · wf-form4_167831226592079.xml · derivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,637 Underlying: Common Stock · 15,637 shares Expires 2033-03-06 F1 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| December 30, 2022 Filed Jan 30, 2023 19:04 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | OtherCommon Stock | 1,252 | $7.20 | $9,014.40 |
DisclosureSEC source: 0001285550-23-000013 · wf-form5_167510544522847.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,729 F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 17:16 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 4,958 | $10.23 | $50,720.34 |
DisclosureSEC source: 0001285550-22-000056 · wf-form4_166481726876489.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,477 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 20, 2022 Filed Aug 23, 2022 22:12 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Tax withholdingCommon Stock | 583 | $13.24 | $7,718.92 |
DisclosureSEC source: 0001285550-22-000049 · wf-form4_166129274313574.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,435 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Includes 804 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 20:14 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 15,600 | $0.00 Strike: $11.41 | $0.00 |
DisclosureSEC source: 0001285550-22-000022 · wf-form4_165523765989689.xml · derivative · entry 2 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,600 Underlying: Common Stock · 15,600 shares Expires 2032-06-10 F3 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 20:14 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 23,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-22-000022 · wf-form4_165523765989689.xml · nonDerivative · entry 1 D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,214 F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. F2 · balance_after: Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.